Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Analyst picks & changes

Genentech Inc.

(DNA), South San Francisco, Calif.

Protein Design Labs Inc.

(PDLI), Fremont, Calif.

Business: Cancer

Leerink Swann analyst

Read the full 191 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE